Breaking News

Tufts Forum Examines Investigative Site Relationships

More site input proves helpful, while PI landscape remains challenging

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Improved investigative site relationships and effectiveness are top objectives in 2015 for pharma companies and CROs, according to industry R&D executives participating in a roundtable recently hosted by the Tufts Center for the Study of Drug Development.   Sponsors and CROs said soliciting more input from investigative sites to guide study planning and execution are helping to improve clinical trial performance. Also, incorporating anticipated changes in the site landscape, such integration...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters